|

Targeted Systemic Therapy Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 3: 1Phase 2/3: 1

Top Sponsors

  • David Palma1
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1

Indications

  • Cancer2
  • Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma1
  • Gastric (cardia, Body) Cancer1
  • Metastatic Tumor1
  • Esophageal Carcinoma1

Other2 trials

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
Phase 3
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.